Antibiotic Resistance Market Report

Global Antibiotic Resistance Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：181
  • REPORT CODE：GMM826815
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Antibiotic Resistance market report explains the definition, types, applications, major countries, and major players of the Antibiotic Resistance market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Nemesis Bioscience

    • Nabriva Therapeutics

    • The Medicines Company

    • Merck

    • Allergan

    • TPfizer

    • Westway Health

    • BioVersys GmbH

    • Tetraphase Pharmaceuticals

    • Macrolide Pharmaceuticals

    • AmpliPhi Biosciences

    • Melinta Therapeutics

    • Phage Technologies SA

    By Type:

    • Urinary Tract Infection

    • Intra-Abdominal Infections

    • Blood Stream Infections

    • Clostridium Difficile Infections

    • Acute Bacterial Skin and Skin Structure Infections

    • Bacterial Pneumonia

    By End-User:

    • Oxazolidinones

    • Lipoglycopeptides

    • Tetracyclines

    • Cephalosporins

    • Combination therapies

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Antibiotic Resistance Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Antibiotic Resistance Outlook to 2028- Original Forecasts

    • 2.2 Antibiotic Resistance Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Antibiotic Resistance Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Antibiotic Resistance Market- Recent Developments

    • 6.1 Antibiotic Resistance Market News and Developments

    • 6.2 Antibiotic Resistance Market Deals Landscape

    7 Antibiotic Resistance Raw Materials and Cost Structure Analysis

    • 7.1 Antibiotic Resistance Key Raw Materials

    • 7.2 Antibiotic Resistance Price Trend of Key Raw Materials

    • 7.3 Antibiotic Resistance Key Suppliers of Raw Materials

    • 7.4 Antibiotic Resistance Market Concentration Rate of Raw Materials

    • 7.5 Antibiotic Resistance Cost Structure Analysis

      • 7.5.1 Antibiotic Resistance Raw Materials Analysis

      • 7.5.2 Antibiotic Resistance Labor Cost Analysis

      • 7.5.3 Antibiotic Resistance Manufacturing Expenses Analysis

    8 Global Antibiotic Resistance Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Antibiotic Resistance Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Antibiotic Resistance Export by Region (Top 10 Countries) (2017-2028)

    9 Global Antibiotic Resistance Market Outlook by Types and Applications to 2022

    • 9.1 Global Antibiotic Resistance Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Urinary Tract Infection Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Intra-Abdominal Infections Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Blood Stream Infections Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Clostridium Difficile Infections Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Acute Bacterial Skin and Skin Structure Infections Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Bacterial Pneumonia Consumption and Growth Rate (2017-2022)

    • 9.2 Global Antibiotic Resistance Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oxazolidinones Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Lipoglycopeptides Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Tetracyclines Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cephalosporins Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Combination therapies Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Antibiotic Resistance Market Analysis and Outlook till 2022

    • 10.1 Global Antibiotic Resistance Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Antibiotic Resistance Consumption (2017-2022)

      • 10.2.2 Canada Antibiotic Resistance Consumption (2017-2022)

      • 10.2.3 Mexico Antibiotic Resistance Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Antibiotic Resistance Consumption (2017-2022)

      • 10.3.2 UK Antibiotic Resistance Consumption (2017-2022)

      • 10.3.3 Spain Antibiotic Resistance Consumption (2017-2022)

      • 10.3.4 Belgium Antibiotic Resistance Consumption (2017-2022)

      • 10.3.5 France Antibiotic Resistance Consumption (2017-2022)

      • 10.3.6 Italy Antibiotic Resistance Consumption (2017-2022)

      • 10.3.7 Denmark Antibiotic Resistance Consumption (2017-2022)

      • 10.3.8 Finland Antibiotic Resistance Consumption (2017-2022)

      • 10.3.9 Norway Antibiotic Resistance Consumption (2017-2022)

      • 10.3.10 Sweden Antibiotic Resistance Consumption (2017-2022)

      • 10.3.11 Poland Antibiotic Resistance Consumption (2017-2022)

      • 10.3.12 Russia Antibiotic Resistance Consumption (2017-2022)

      • 10.3.13 Turkey Antibiotic Resistance Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Antibiotic Resistance Consumption (2017-2022)

      • 10.4.2 Japan Antibiotic Resistance Consumption (2017-2022)

      • 10.4.3 India Antibiotic Resistance Consumption (2017-2022)

      • 10.4.4 South Korea Antibiotic Resistance Consumption (2017-2022)

      • 10.4.5 Pakistan Antibiotic Resistance Consumption (2017-2022)

      • 10.4.6 Bangladesh Antibiotic Resistance Consumption (2017-2022)

      • 10.4.7 Indonesia Antibiotic Resistance Consumption (2017-2022)

      • 10.4.8 Thailand Antibiotic Resistance Consumption (2017-2022)

      • 10.4.9 Singapore Antibiotic Resistance Consumption (2017-2022)

      • 10.4.10 Malaysia Antibiotic Resistance Consumption (2017-2022)

      • 10.4.11 Philippines Antibiotic Resistance Consumption (2017-2022)

      • 10.4.12 Vietnam Antibiotic Resistance Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Antibiotic Resistance Consumption (2017-2022)

      • 10.5.2 Colombia Antibiotic Resistance Consumption (2017-2022)

      • 10.5.3 Chile Antibiotic Resistance Consumption (2017-2022)

      • 10.5.4 Argentina Antibiotic Resistance Consumption (2017-2022)

      • 10.5.5 Venezuela Antibiotic Resistance Consumption (2017-2022)

      • 10.5.6 Peru Antibiotic Resistance Consumption (2017-2022)

      • 10.5.7 Puerto Rico Antibiotic Resistance Consumption (2017-2022)

      • 10.5.8 Ecuador Antibiotic Resistance Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Antibiotic Resistance Consumption (2017-2022)

      • 10.6.2 Kuwait Antibiotic Resistance Consumption (2017-2022)

      • 10.6.3 Oman Antibiotic Resistance Consumption (2017-2022)

      • 10.6.4 Qatar Antibiotic Resistance Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Antibiotic Resistance Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Antibiotic Resistance Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Antibiotic Resistance Consumption (2017-2022)

      • 10.7.2 South Africa Antibiotic Resistance Consumption (2017-2022)

      • 10.7.3 Egypt Antibiotic Resistance Consumption (2017-2022)

      • 10.7.4 Algeria Antibiotic Resistance Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Antibiotic Resistance Consumption (2017-2022)

      • 10.8.2 New Zealand Antibiotic Resistance Consumption (2017-2022)

    11 Global Antibiotic Resistance Competitive Analysis

    • 11.1 Nemesis Bioscience

      • 11.1.1 Nemesis Bioscience Company Details

      • 11.1.2 Nemesis Bioscience Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Nemesis Bioscience Antibiotic Resistance Main Business and Markets Served

      • 11.1.4 Nemesis Bioscience Antibiotic Resistance Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Nabriva Therapeutics

      • 11.2.1 Nabriva Therapeutics Company Details

      • 11.2.2 Nabriva Therapeutics Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Nabriva Therapeutics Antibiotic Resistance Main Business and Markets Served

      • 11.2.4 Nabriva Therapeutics Antibiotic Resistance Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 The Medicines Company

      • 11.3.1 The Medicines Company Company Details

      • 11.3.2 The Medicines Company Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 The Medicines Company Antibiotic Resistance Main Business and Markets Served

      • 11.3.4 The Medicines Company Antibiotic Resistance Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck

      • 11.4.1 Merck Company Details

      • 11.4.2 Merck Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck Antibiotic Resistance Main Business and Markets Served

      • 11.4.4 Merck Antibiotic Resistance Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Allergan

      • 11.5.1 Allergan Company Details

      • 11.5.2 Allergan Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Allergan Antibiotic Resistance Main Business and Markets Served

      • 11.5.4 Allergan Antibiotic Resistance Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 TPfizer

      • 11.6.1 TPfizer Company Details

      • 11.6.2 TPfizer Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 TPfizer Antibiotic Resistance Main Business and Markets Served

      • 11.6.4 TPfizer Antibiotic Resistance Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Westway Health

      • 11.7.1 Westway Health Company Details

      • 11.7.2 Westway Health Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Westway Health Antibiotic Resistance Main Business and Markets Served

      • 11.7.4 Westway Health Antibiotic Resistance Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 BioVersys GmbH

      • 11.8.1 BioVersys GmbH Company Details

      • 11.8.2 BioVersys GmbH Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 BioVersys GmbH Antibiotic Resistance Main Business and Markets Served

      • 11.8.4 BioVersys GmbH Antibiotic Resistance Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Tetraphase Pharmaceuticals

      • 11.9.1 Tetraphase Pharmaceuticals Company Details

      • 11.9.2 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Tetraphase Pharmaceuticals Antibiotic Resistance Main Business and Markets Served

      • 11.9.4 Tetraphase Pharmaceuticals Antibiotic Resistance Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Macrolide Pharmaceuticals

      • 11.10.1 Macrolide Pharmaceuticals Company Details

      • 11.10.2 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Macrolide Pharmaceuticals Antibiotic Resistance Main Business and Markets Served

      • 11.10.4 Macrolide Pharmaceuticals Antibiotic Resistance Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 AmpliPhi Biosciences

      • 11.11.1 AmpliPhi Biosciences Company Details

      • 11.11.2 AmpliPhi Biosciences Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 AmpliPhi Biosciences Antibiotic Resistance Main Business and Markets Served

      • 11.11.4 AmpliPhi Biosciences Antibiotic Resistance Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Melinta Therapeutics

      • 11.12.1 Melinta Therapeutics Company Details

      • 11.12.2 Melinta Therapeutics Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Melinta Therapeutics Antibiotic Resistance Main Business and Markets Served

      • 11.12.4 Melinta Therapeutics Antibiotic Resistance Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Phage Technologies SA

      • 11.13.1 Phage Technologies SA Company Details

      • 11.13.2 Phage Technologies SA Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Phage Technologies SA Antibiotic Resistance Main Business and Markets Served

      • 11.13.4 Phage Technologies SA Antibiotic Resistance Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Antibiotic Resistance Market Outlook by Types and Applications to 2028

    • 12.1 Global Antibiotic Resistance Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Urinary Tract Infection Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Intra-Abdominal Infections Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Blood Stream Infections Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Clostridium Difficile Infections Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Acute Bacterial Skin and Skin Structure Infections Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Bacterial Pneumonia Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Antibiotic Resistance Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Oxazolidinones Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Lipoglycopeptides Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Tetracyclines Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Cephalosporins Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Combination therapies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Antibiotic Resistance Market Analysis and Outlook to 2028

    • 13.1 Global Antibiotic Resistance Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.2.2 Canada Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Antibiotic Resistance Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.2 UK Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.3 Spain Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.5 France Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.6 Italy Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.8 Finland Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.9 Norway Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.11 Poland Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.12 Russia Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Antibiotic Resistance Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.2 Japan Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.3 India Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Antibiotic Resistance Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.5.3 Chile Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.5.6 Peru Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Antibiotic Resistance Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.6.3 Oman Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Antibiotic Resistance Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Antibiotic Resistance Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Antibiotic Resistance Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Antibiotic Resistance Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Antibiotic Resistance

    • Figure of Antibiotic Resistance Picture

    • Table Global Antibiotic Resistance Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Antibiotic Resistance Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Urinary Tract Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Intra-Abdominal Infections Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Stream Infections Consumption and Growth Rate (2017-2022)

    • Figure Global Clostridium Difficile Infections Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Bacterial Skin and Skin Structure Infections Consumption and Growth Rate (2017-2022)

    • Figure Global Bacterial Pneumonia Consumption and Growth Rate (2017-2022)

    • Figure Global Oxazolidinones Consumption and Growth Rate (2017-2022)

    • Figure Global Lipoglycopeptides Consumption and Growth Rate (2017-2022)

    • Figure Global Tetracyclines Consumption and Growth Rate (2017-2022)

    • Figure Global Cephalosporins Consumption and Growth Rate (2017-2022)

    • Figure Global Combination therapies Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Antibiotic Resistance Consumption by Country (2017-2022)

    • Table North America Antibiotic Resistance Consumption by Country (2017-2022)

    • Figure United States Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Canada Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Mexico Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Table Europe Antibiotic Resistance Consumption by Country (2017-2022)

    • Figure Germany Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure UK Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Spain Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Belgium Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure France Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Italy Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Denmark Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Finland Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Norway Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Sweden Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Poland Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Russia Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Turkey Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Table APAC Antibiotic Resistance Consumption by Country (2017-2022)

    • Figure China Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Japan Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure India Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure South Korea Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Thailand Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Singapore Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Philippines Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Table South America Antibiotic Resistance Consumption by Country (2017-2022)

    • Figure Brazil Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Colombia Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Chile Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Argentina Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Peru Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Table GCC Antibiotic Resistance Consumption by Country (2017-2022)

    • Figure Bahrain Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Oman Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Qatar Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Table Africa Antibiotic Resistance Consumption by Country (2017-2022)

    • Figure Nigeria Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure South Africa Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Egypt Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Algeria Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Table Oceania Antibiotic Resistance Consumption by Country (2017-2022)

    • Figure Australia Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Table Nemesis Bioscience Company Details

    • Table Nemesis Bioscience Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nemesis Bioscience Antibiotic Resistance Main Business and Markets Served

    • Table Nemesis Bioscience Antibiotic Resistance Product Portfolio

    • Table Nabriva Therapeutics Company Details

    • Table Nabriva Therapeutics Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nabriva Therapeutics Antibiotic Resistance Main Business and Markets Served

    • Table Nabriva Therapeutics Antibiotic Resistance Product Portfolio

    • Table The Medicines Company Company Details

    • Table The Medicines Company Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table The Medicines Company Antibiotic Resistance Main Business and Markets Served

    • Table The Medicines Company Antibiotic Resistance Product Portfolio

    • Table Merck Company Details

    • Table Merck Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Antibiotic Resistance Main Business and Markets Served

    • Table Merck Antibiotic Resistance Product Portfolio

    • Table Allergan Company Details

    • Table Allergan Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Antibiotic Resistance Main Business and Markets Served

    • Table Allergan Antibiotic Resistance Product Portfolio

    • Table TPfizer Company Details

    • Table TPfizer Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table TPfizer Antibiotic Resistance Main Business and Markets Served

    • Table TPfizer Antibiotic Resistance Product Portfolio

    • Table Westway Health Company Details

    • Table Westway Health Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Westway Health Antibiotic Resistance Main Business and Markets Served

    • Table Westway Health Antibiotic Resistance Product Portfolio

    • Table BioVersys GmbH Company Details

    • Table BioVersys GmbH Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioVersys GmbH Antibiotic Resistance Main Business and Markets Served

    • Table BioVersys GmbH Antibiotic Resistance Product Portfolio

    • Table Tetraphase Pharmaceuticals Company Details

    • Table Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tetraphase Pharmaceuticals Antibiotic Resistance Main Business and Markets Served

    • Table Tetraphase Pharmaceuticals Antibiotic Resistance Product Portfolio

    • Table Macrolide Pharmaceuticals Company Details

    • Table Macrolide Pharmaceuticals Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Macrolide Pharmaceuticals Antibiotic Resistance Main Business and Markets Served

    • Table Macrolide Pharmaceuticals Antibiotic Resistance Product Portfolio

    • Table AmpliPhi Biosciences Company Details

    • Table AmpliPhi Biosciences Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table AmpliPhi Biosciences Antibiotic Resistance Main Business and Markets Served

    • Table AmpliPhi Biosciences Antibiotic Resistance Product Portfolio

    • Table Melinta Therapeutics Company Details

    • Table Melinta Therapeutics Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Melinta Therapeutics Antibiotic Resistance Main Business and Markets Served

    • Table Melinta Therapeutics Antibiotic Resistance Product Portfolio

    • Table Phage Technologies SA Company Details

    • Table Phage Technologies SA Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Phage Technologies SA Antibiotic Resistance Main Business and Markets Served

    • Table Phage Technologies SA Antibiotic Resistance Product Portfolio

    • Figure Global Urinary Tract Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intra-Abdominal Infections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Stream Infections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clostridium Difficile Infections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Bacterial Skin and Skin Structure Infections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bacterial Pneumonia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oxazolidinones Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lipoglycopeptides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tetracyclines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cephalosporins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combination therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antibiotic Resistance Consumption Forecast by Country (2022-2028)

    • Table North America Antibiotic Resistance Consumption Forecast by Country (2022-2028)

    • Figure United States Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Antibiotic Resistance Consumption Forecast by Country (2022-2028)

    • Figure Germany Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Antibiotic Resistance Consumption Forecast by Country (2022-2028)

    • Figure China Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Antibiotic Resistance Consumption Forecast by Country (2022-2028)

    • Figure Brazil Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Antibiotic Resistance Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Antibiotic Resistance Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Antibiotic Resistance Consumption Forecast by Country (2022-2028)

    • Figure Australia Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US